Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) + pembrolizumab (pembro) + carboplatin (carbo) +- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC).
Carboplatin;Pembrolizumab;Tisotumab Vedotin;Bevacizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) + pembrolizumab (pembro) + carboplatin (carbo) +- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC). ### Output: Carboplatin;Pembrolizumab;Tisotumab Vedotin;Bevacizumab